Exhale

The official blog of the Lung Institute.

This Week in Lung Disease: Cellular Treatment Could Change Root Canals

15 Jul 2016
| Under Lifestyle | Posted by
| 4 Comments
This Week in Lung Disease

Lung disease news is not always easy to find. That’s why we at the Lung Institute search the internet each week for the latest news involving chronic lung disease and cellular therapy – so you don’t have to.

Cellular Research Could Lead to the End of Root Canals

Trips to the dentist may become a little less painful in the future.

Scientists from the University of Nottingham and Harvard University’s Wyss Institute are developing a new treatment that could do away with dreaded root canals. The process involves using the patient’s cells to help heal damaged teeth. This treatment is still in the early stages of development and has yet to be tested in people, but the scientists are optimistic about its future.

For more information about his procedure, go to CBS News.

New Lung Disease Treatments Aims to ‘Zap’ the Pain Away

A new procedure aimed to help lung disease patients breathe easier is causing quite a “shock.” An operation is being tested in hospitals in London using tiny electrodes to burn away damaged nerves in the lungs. For people with lung diseases, such as COPD, the nerves in the lungs become overactive and can create more mucus or constrict airflow. The hour-long procedure involves a surgeon sending a catheter with a balloon and electrode at the end down into the patient’s lungs. Once in the lungs, the balloon inflates to hold the electrode in place as the heat from the electrode deadens the over active nerves.

To find out more about this procedure, please go to The Daily Mail.

Rolling Walkers Help COPD Patients Walk with Ease

For those battling chronic lung disease, it might be time to get a new set of wheels. According to a trial conducted in the Netherlands, those with COPD and other chronic lung diseases found walking outdoors to be much easier with the use of a rolling walker, also known as a rollator.

In the trial, those with COPD who used a rollator walked much further and reported feeling much better using it versus people who walked without an aid device.

The lead researcher on the trial said rollators can be beneficial for those with moderate to severe COPD, but not everyone will benefit as it’s a case-by-case basis.

For more information, please check out Fox News’ website.

D.C. Braces for Heat Wave Bringing Poor Air Quality

People living around our nation’s capital are stuck in a massive heatwave. Washington D.C. is in the midst of a streak of high temperatures in the upper 90s leaving those with and without lung disease feeling the effects.

This heat wave has caused the National Weather Service to issue a code orange air quality alert, meaning small children and adults with chronic lung disease may be at risk of heat exhaustion. If you or someone you know battles chronic lung disease and lives around the D.C. area, please advise them to be safe and limit their exposure to the heat and humidity.

For more information, please read the rest of the story at The Washington Times.

Keep checking in with us for the latest lung disease news. If you or someone you know has a chronic lung disease, remember there is hope. At the Lung Institute, we specialize in cellular therapys for those with lung disease such as COPD, pulmonary fibrosis and interstitial lung disease. For more information about the Lung Institute or cellular therapy, please contact one of our patient coordinators by calling (800) 729-3065 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.